HALO Competitors & Alternatives
Compare Halozyme Therapeutics Inc with similar stocks in the same industry
Biotechnology
HALO
Main Stock$82.54
Tradestie Score
59
Market Cap
$8.77B
P/E Ratio
29.2
Revenue Growth
0.4%
Analyst Upside
+5.3%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EXEL
Exelixis Inc
|
$53.03
|
$11.09B | 18.5 | 47 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$33.91
|
$10.76B | - | 56 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$54.82
|
$10.74B | - | 51 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$60.02
|
$10.53B | 43.6 | 53 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$51.77
|
$10.49B | - | 59 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$80.09
|
$10.22B | - | 56 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$467.32
|
$10.01B | - | 52 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.09
|
$9.33B | 102.9 | 50 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$114.49
|
$8.88B | 262.9 | 59 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$187.53
|
$8.57B | - | 60 | Compare |
More HALO Analysis
Data updated: Aug 02, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry